Recent Articles

• 
  Medical / Drug Development

  Smart Patch Uses Light to Control Drug Doses

  Schematic of a photo-pharmaceutical combination therapy using an OLED patch. (Provided by KAIST. Resale and DB prohibited) 2026.4.13/News1 A “smart patch” that accelerates wound healing more than ointments or adhesive bandages has been developed. KAIST announced on the 13th that a research team led

  2026.04.13
• 
  AI Healthcare

  ARPI Only Korean Firm at Mayo Clinic Showcase

  Photo courtesy of ARPI Medical AI company ARPI (CEO Kim Joong-hee) announced that it participated in the “Mayo Clinic Platform_Accelerate Showcase,” held in Rochester, Minnesota, United States, from the 7th to the 8th. ARPI was the only Korean company among the 25 global healthcare companies partici

  2026.04.09
• 
  Medical / Research

  Cervical Cancer Test Uses Vaginal Discharge

  Oh Young-taek, Professor of Obstetrics and Gynecology at Korea University Ansan Hospital. Courtesy of Korea University Ansan Hospital Professor Oh Young-taek of the Department of Obstetrics and Gynecology at Korea University Ansan Hospital has presented a non-invasive precision diagnostic technology

  2026.04.08
• 
  AI Healthcare

  Health capsule: Model predicts delayed relapse in young breast cancer

  ■ Development of a Predictive Model for Delayed Recurrence in Young Breast Cancer Patients, etc. A model has been developed that can predict the risk of recurrence after 5 years in young breast cancer patients. Estrogen receptor-positive (ER+) and human epidermal growth factor receptor 2-negative (H

  2026.04.08
• 
  MedTech

  PharmaResearch Launches ‘Ziner’ Perineal Wound Dressing

  PharmaResearch announced on the 7th that it has launched “Zyner,” an adhesive transparent wound dressing using its proprietary DOT PN (Polynucleotide) technology. Photo provided by PharmaResearch PharmaResearch is moving to expand its portfolio into the obstetrics and gynecology sector based on its

  2026.04.07
• 
  Vaccine / Biotech

  ‘Stronger With Less’ Korea Research Develops High-Efficiency Vaccine Platform

  Schematic diagram of a next-generation low-dose mRNA vaccine platform. Provided by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) The Korea Research Institute of Bioscience and Biotechnology (KRIBB) announced on the 7th that it has developed a design method for a next-generatio

  2026.04.07
• 
  Medical / Drug Development

  SK Biopharm Unveils Radiopharmaceutical at World’s Largest Cancer Meeting

  SK Biopharm announced on the 6th that it will present preclinical research results for its radiopharmaceutical (RPT) therapeutic candidate “SKL35501” and imaging diagnostic agent “SKL35502” at the “2026 American Association for Cancer Research (AACR) Annual Meeting,” to be held in San Diego, Califor

  2026.04.06
• 
  Biopharma

  LG Chem Licenses Japan’s Top Endometriosis Drug

  Product image of Dinagest, an endometriosis treatment by Mochida Pharmaceutical in Japan. Provided by Mochida Pharmaceutical LG Chem is strengthening its women’s health portfolio by introducing Japan’s No. 1 endometriosis treatment (based on the Japanese dienogest ingredient market).LG Chem announce

  2026.04.03
• 
  MOU / Drug Development

  SK Biopharm, Seoul Bio Hub Partner to Mentor Startups

  SK Biopharmaceuticals and Seoul Bio Hub hold a ceremony to sign an agreement and take a commemorative photo. (From left) Kim Hyun-woo, Head of Seoul Bio Hub Center; Kim Sung-young, CEO of Three Brooks Therapeutics; Kang Hae-ra, Director of the Advanced Industry Division at the Seoul Metropolitan Gov

  2026.04.03
• 
  Global Business

  Eating to Lose Weight: Obesity Pill Wars

  The “oral obesity drug” race has begun. According to Reuters and other foreign media on the 2nd (local time), the US Food and Drug Administration (FDA) on the 1st approved Eli Lilly’s oral obesity treatment “Poundayo (orforglipron).” Following Novo Nordisk’s launch of oral Wegovy at the beginning of

  2026.04.03